Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| SKCM | Skin Cutaneous Melanoma | S324S | Silent | 2 |
| BLCA | Bladder urothelial carcinoma | K114K | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | P148A | Missense | 1 |
| BRCA | Breast invasive carcinoma | R538H | Missense | 1 |
| CESC | Cervical and endocervical cancers | E237K | Missense | 1 |
| CESC | Cervical and endocervical cancers | E485D | Missense | 1 |
| CESC | Cervical and endocervical cancers | R316R | Silent | 1 |
| CESC | Cervical and endocervical cancers | R316W | Missense | 1 |
| COAD | Colon adenocarcinoma | D98E | Missense | 1 |
| COAD | Colon adenocarcinoma | T130A | Missense | 1 |
| GBM | Glioblastoma multiforme | V118I | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | G201R | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | M194L | Missense | 1 |
| LGG | Brain Lower Grade Glioma | C434Y | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | E237K | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | G150V | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | R356W | Missense | 1 |
| LUAD | Lung adenocarcinoma | A191A | Silent | 1 |
| LUAD | Lung adenocarcinoma | A450A | Silent | 1 |
| LUAD | Lung adenocarcinoma | G435R | Missense | 1 |
| LUAD | Lung adenocarcinoma | I330I | Silent | 1 |
| LUAD | Lung adenocarcinoma | L255L | Silent | 1 |
| LUAD | Lung adenocarcinoma | L308V | Missense | 1 |
| LUAD | Lung adenocarcinoma | P282T | Missense | 1 |
| LUAD | Lung adenocarcinoma | P384A | Missense | 1 |
| LUAD | Lung adenocarcinoma | T151T | Silent | 1 |
| LUSC | Lung squamous cell carcinoma | G269G | Silent | 1 |
| LUSC | Lung squamous cell carcinoma | P109T | Missense | 1 |
| OV | Ovarian serous cystadenocarcinoma | L397L | Silent | 1 |
| PAAD | Pancreatic adenocarcinoma | A300V | Missense | 1 |
| PAAD | Pancreatic adenocarcinoma | S412S | Silent | 1 |
| READ | Rectum adenocarcinoma | H35H | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | A205T | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | A284A | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | E137K | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | E329K | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | E508K | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | G374R | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | I330I | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | K131K | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | K245K | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | L366L | Silent | 1 |
| SKCM | Skin Cutaneous Melanoma | P115L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P280S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P367S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | R203Q | Missense | 1 |
| STAD | Stomach adenocarcinoma | A117V | Missense | 1 |
| STAD | Stomach adenocarcinoma | A450T | Missense | 1 |
| STAD | Stomach adenocarcinoma | C434Y | Missense | 1 |
| STAD | Stomach adenocarcinoma | L323M | Missense | 1 |
| STAD | Stomach adenocarcinoma | R456H | Missense | 1 |
| TGCT | Testicular Germ Cell Tumors | S518V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A170T | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A191V | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E237K | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | G91D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | Q69H | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S185P | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S372L | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 5.6 | 2.4 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 2.4 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 5.6 | 7.1 | 0 |
| COAD | Colon adenocarcinoma | 367 | 0 | 4.8 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 2.4 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 4.8 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 2.4 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 0 | 7.1 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 27.8 | 9.5 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 5.6 | 2.4 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 5.6 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 5.6 | 2.4 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 5.6 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 38.9 | 21.4 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 0 | 11.9 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 2.4 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 0 | 16.7 | 0 |